TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd announced at its Annual General Meeting that Richard, the founding Managing Director, will retire in early 2026 after 25 years with the company. The recruitment process for his successor is well underway, ensuring a smooth leadership transition. The company acknowledged Richard’s significant contributions and the promising future opportunities for Proteomics International.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, a subsidiary of PILL, is a medical technology company based in Perth, Western Australia. It specializes in precision diagnostics and bio-analytical services, focusing on proteomics, which involves the large-scale study of protein structures and functions. The company’s mission is to enhance the quality of life through innovative tools that improve disease treatment.
Average Trading Volume: 288,090
Technical Sentiment Signal: Sell
Current Market Cap: A$52.38M
See more data about PIQ stock on TipRanks’ Stock Analysis page.